A
Ava
The world’s first smart bracelet to precisely track your fertility, pregnancy and health – all while you sleep
About Ava
Ava Women operates in the health technology sector, focusing on fertility tracking for women trying to conceive. The company offers a wearable device that monitors multiple physiological parameters to identify the most fertile days in a woman's cycle. This device is particularly beneficial for women who have been trying to get pregnant for an extended period or those over the age of 35. Ava Women's primary clients are women seeking to optimize their chances of conception. The company operates in the global fertility market, which includes both direct consumers and healthcare professionals.
Read full description
Ava Women's business model revolves around the sale of its wearable fertility tracker and accompanying subscription services for data analysis and personalized insights. Revenue is generated through the initial purchase of the device and ongoing subscription fees for advanced features and continuous monitoring.
The company leverages scientific research and clinical studies to validate its product's effectiveness, thereby building trust and credibility among its users. Ava Women also collaborates with healthcare providers to integrate its technology into broader fertility treatment plans.
At a glance
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Zurich, Switzerland
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 83.0/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Fertility, Data Analytics, Pregnancy, Remote Monitoring, Bracelets, Spinout
- Technology
- Big Data, Connected Device
- Business model
- Manufacturing, Marketplace & ecommerce
- Client focus
- b2c
- Investment activity
- 2 companies, latest Aug 2023
- Capital deployed
- $2.3B
- Preferred round
- CONVERTIBLE
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jul 2022 | $0 | — | FemTec Health | ↗ |
| SERIES B✓Equity / VC | May 2018 | $30M | $120M | Polytech Ventures · Alpana Ventures · b2venture · SVC | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Ava is 23K monthly website visits, down 45.2% over the last three months. Ava's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Venture Kick
ZKB - Zürcher Kantonalbank
Swisscom Ventures
DCM
Innovation Endeavors
Khosla Ventures
Series A10 investors entered at this stage
- PEPolytech Ecosystem
EuroUS Ventures
Alpana Ventures
Polytech Ventures
Founderful
Blue Ocean Ventures
Global Sources
Boltendahl International Partners
b2venture- SVSVC
Other known investors7 additional known investors
CSEM
FemTec Health
Swissnex
University of St.Gallen
G4A
Gerrit Jurilj
Plug and Play
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ava on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ava’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.